[go: up one dir, main page]

WO2001089511A3 - Acetylsalicylsäure enthaltendes superfizielles therapeutisches system zur behandlung von hautschmerzen - Google Patents

Acetylsalicylsäure enthaltendes superfizielles therapeutisches system zur behandlung von hautschmerzen Download PDF

Info

Publication number
WO2001089511A3
WO2001089511A3 PCT/EP2001/005323 EP0105323W WO0189511A3 WO 2001089511 A3 WO2001089511 A3 WO 2001089511A3 EP 0105323 W EP0105323 W EP 0105323W WO 0189511 A3 WO0189511 A3 WO 0189511A3
Authority
WO
WIPO (PCT)
Prior art keywords
active agent
therapeutic system
treating skin
system containing
acetylsalicylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/005323
Other languages
English (en)
French (fr)
Other versions
WO2001089511A2 (de
Inventor
Torsten Selzer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of WO2001089511A2 publication Critical patent/WO2001089511A2/de
Publication of WO2001089511A3 publication Critical patent/WO2001089511A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Eine topische Darreichungsform zur Behandlung von Hautschmerzen, mit einem Gehalt an Acetylsalicylsäure und/oder mindestens einem anderen Wirkstoff aus der Gruppe der nicht-steroidalen Antiphlogistika, ist dadurch gekennzeichnet, dass die Darreichungsform in Form eines superfiziellen therapeutischen Systems ausgebildet ist, welches eine wirkstoffundurchlässige Trägerschicht, ein wirkstoffhaltiges Reservoir, eine Haftklebeschicht zur Befestigung auf der Haut und eine vor der Applikation zu entfernende ablösbare Schutzschicht aufweist, und welches den/die Wirkstoff(e) kontinuierlich an die Haut abgibt.
PCT/EP2001/005323 2000-05-23 2001-05-10 Acetylsalicylsäure enthaltendes superfizielles therapeutisches system zur behandlung von hautschmerzen Ceased WO2001089511A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2000125328 DE10025328A1 (de) 2000-05-23 2000-05-23 Acetylsalicylsäure enthaltendes superfizielles therapeutisches System zur Behandlung von Hautschmerzen
DE10025328.8 2000-05-23

Publications (2)

Publication Number Publication Date
WO2001089511A2 WO2001089511A2 (de) 2001-11-29
WO2001089511A3 true WO2001089511A3 (de) 2002-05-16

Family

ID=7643133

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/005323 Ceased WO2001089511A2 (de) 2000-05-23 2001-05-10 Acetylsalicylsäure enthaltendes superfizielles therapeutisches system zur behandlung von hautschmerzen

Country Status (2)

Country Link
DE (1) DE10025328A1 (de)
WO (1) WO2001089511A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI290464B (en) * 2000-09-01 2007-12-01 Novartis Consumer Health Sa Treatment of burns
DE10236319A1 (de) * 2002-08-08 2004-02-19 Beiersdorf Ag Hautfreundliche Wirkstoffpflaster auf der Basis von SBC mit mindestens einem pharmazeutischen Wirkstoff mit einem Gehalt von mindestens 34 Gew.-% und dessen Herstellung

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4476115A (en) * 1983-07-05 1984-10-09 Reed Raymond E Analgesic composition and method of treating subdermal pain
US4665063A (en) * 1983-06-13 1987-05-12 Rafa Laboratories Ltd. Method of treating acne
EP0379933A2 (de) * 1989-01-20 1990-08-01 LTS Lohmann Therapie-Systeme GmbH & Co. KG Superfizielles therapeutisches System mit einem Gehalt an einem antineoplastischen Wirkstoff, insbesondere 5-Fluoruracil
EP0439344A2 (de) * 1990-01-24 1991-07-31 McNEIL-PPC, INC. Verfahren zur transdermalen Verabreichung von Ibuprofen mittels eines wässrig-alkoholischen Gels
JPH1053525A (ja) * 1996-06-06 1998-02-24 Bitakain Seiyaku Kk 疼痛治療剤
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
WO2001026636A1 (de) * 1999-10-13 2001-04-19 Lts Lohmann Therapie-Systeme Ag Superfizielles therapeutisches system zur topischen applikation von acetylsalicylsäure zur behandlung von akne-erkrankungen

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665063A (en) * 1983-06-13 1987-05-12 Rafa Laboratories Ltd. Method of treating acne
US4476115A (en) * 1983-07-05 1984-10-09 Reed Raymond E Analgesic composition and method of treating subdermal pain
EP0379933A2 (de) * 1989-01-20 1990-08-01 LTS Lohmann Therapie-Systeme GmbH & Co. KG Superfizielles therapeutisches System mit einem Gehalt an einem antineoplastischen Wirkstoff, insbesondere 5-Fluoruracil
EP0439344A2 (de) * 1990-01-24 1991-07-31 McNEIL-PPC, INC. Verfahren zur transdermalen Verabreichung von Ibuprofen mittels eines wässrig-alkoholischen Gels
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
JPH1053525A (ja) * 1996-06-06 1998-02-24 Bitakain Seiyaku Kk 疼痛治療剤
WO2001026636A1 (de) * 1999-10-13 2001-04-19 Lts Lohmann Therapie-Systeme Ag Superfizielles therapeutisches system zur topischen applikation von acetylsalicylsäure zur behandlung von akne-erkrankungen

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 1998, no. 06 30 April 1998 (1998-04-30) *

Also Published As

Publication number Publication date
DE10025328A1 (de) 2001-12-06
WO2001089511A2 (de) 2001-11-29

Similar Documents

Publication Publication Date Title
MXPA02005006A (es) Banda adhesiva.
TW349024B (en) Freeze-dried liposome delivery system for application of skin treatment agents
WO2001054679A3 (en) Transdermal composition containing an anesthetic and a vasodilator agent
PT2450043T (pt) Composição farmacêutica para uso dérmico no tratamento de psoríase compreendendo calcipotriol e betametasona
DK0573576T3 (da) Midler til topisk administration af farmaceutisk aktive stoffer
NO992674L (no) Konturen til et transdermalt terapeutisk system
FI961282L (fi) Transdermaalinen terapeuttinen systeemi, jossa on asetyylisalisyylihappo vaikuttavana aineena
WO2002030506A3 (en) Transdermal method
WO2001068060A3 (de) Stabilisierte übersättigte transdermale therapeutische matrixsysteme
GR3026503T3 (en) Dexpanthenol-containing plaster for the transdermal application of steroid hormones.
WO2001013899A3 (de) Wirkstoffhaltiges therapeutisches system mit mindestens zwei polymerhaltigen schichten
CA2387143A1 (en) Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin
ATE297717T1 (de) Heparin und diclofenac enthaltendes topisches pflaster
WO2002053090A3 (fr) Association medicamenteuse d'une biguanine (metformine) et d'arginine
WO2001026637A3 (de) Transdermales therapeutisches system zur abgabe von acetylsalicylsäure und/oder salicylsäure
WO2002022109A3 (en) Patch comprising diclofenac
WO2002017928A3 (de) Transdermales therapeutisches system zur abgabe von exemestan
IL92924A0 (en) Superficial therapeutic system comprising an antineoplastic active substance
WO2001089511A3 (de) Acetylsalicylsäure enthaltendes superfizielles therapeutisches system zur behandlung von hautschmerzen
WO2005082428A3 (de) Pflaster mit reduzierter hautirritation
SE0103276L (sv) Anordning för administrering av salva till en hudyta
EP0693479A4 (de) Neue aconitin ähnliche verbindung und antipyretisches, analgetisches und entzündungshemmendes mittel
NO993435L (no) Transdermalt acetylsalicylsyre inneholdende terapeutisk system med forsterket resorpsjon
ZA987006B (en) Transdermal therapeutic system (TTS) for delivering active ingredient through the skin to a body and method for application to the skin
WO2001041771A3 (de) Acetylsalicylsäure enthaltendes transdermales system zur behandlung von migräne

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP KR US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): JP KR US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP